Parkinson's Trial NCT06464029
Pinpoint causes of balance problems
- Trial ID
- NCT06464029
- Official Title
- Pathways Mediating Impaired Postural Control in Parkinson's Disease
- Goal
- Pinpoint causes of balance problems
- Status
- RECRUITING
- Sponsor
- University of Minnesota
- Study Type
- OBSERVATIONAL
- Enrollment
- 160 participants
- Conditions
- Parkinson Disease
Summary For Families
The goal is to pinpoint which brain and body pathways cause the balance and postural control problems people with Parkinson's often experience, so future therapies can better prevent falls. Researchers will observe people doing standing and walking tasks in the lab while measuring how sensory input, muscle responses, and neural control differ between Parkinson's and healthy volunteers; no drugs or surgeries are given, this is an observational study. People with implanted devices like deep brain stimulators or pacemakers, on blood thinners, or with seizures, stroke, dementia, recent concussion, major musculoskeletal issues, or other significant neurological disorders are excluded. The study is enrolling adults with idiopathic Parkinson's aged 45 to 80 who can walk 50 meters unaided, plus age- and sex-matched healthy older adults 45 to 80 and a younger control group aged 21 to 44.
Locations
- University of Minnesota, Minneapolis, Minnesota, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to pinpoint which brain and body pathways cause the balance and postural control problems people with Parkinson's often experience, so future therapies can better prevent falls. Researchers will observe people doing standing and walking tasks in the lab while measuring how sensory input, muscle responses, and neural control differ between Parkinson's and healthy volunteers; no drugs or surgeries are given, this is an observational study. People with implanted devices like deep brain stimulators or pacemakers, on blood thinners, or with seizures, stroke, dementia, recent concussion, major musculoskeletal issues, or other significant neurological disorders are excluded. The study is enrolling adults with idiopathic Parkinson's aged 45 to 80 who can walk 50 meters unaided, plus age- and sex-matched healthy older adults 45 to 80 and a younger control group aged 21 to 44.
- Who can participate?
- Participants must be between 45 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.